(Q44525092)

3 December 2017

Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-/-) mice (English)

1 reference

3 December 2017

1 reference

Tetsu Egawa

1

1 reference

3 December 2017

Katsumi Toda

2

1 reference

3 December 2017

Yoshihisa Nemoto

3

1 reference

3 December 2017

Masafumi Ono

4

1 reference

3 December 2017

Naoaki Akisaw

5

1 reference

3 December 2017

Toshiji Saibara

6

1 reference

3 December 2017

Yoshihiro Hayashi

7

1 reference

3 December 2017

Makoto Hiroi

8

1 reference

3 December 2017

Hideaki Enzan

9

1 reference

3 December 2017

Saburo Onishi

10

1 reference

3 December 2017

1 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

38

1 reference

3 December 2017

5

1 reference

3 December 2017

519-523

1 reference

https://scigraph.springernature.com/pub.10.1007/s11745-003-1093-x

3 December 2017

0 references

cites work

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Nonalcoholic fatty liver disease: an agenda for clinical research

1 reference

12 December 2020

Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis

1 reference

12 December 2020

Tamoxifen-induced steatohepatitis

1 reference

12 December 2020

Cholesterol management in theory and practice

1 reference

12 December 2020

Tamoxifen-induced fatty liver in patients with breast cancer

1 reference

12 December 2020

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I

1 reference

12 December 2020

Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice

1 reference

12 December 2020

Developmental, nutritional, and hormonal regulation of tissue-specific expression of the genes encoding various acyl-CoA dehydrogenases and alpha-subunit of electron transfer flavoprotein in rat

1 reference

12 December 2020

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: role for nuclear receptors in cardiac and brown adipose expression

1 reference

12 December 2020

The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins. Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase.

1 reference

12 December 2020

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

12 December 2020

Triglyceride-lowering effect of pitavastatin [corrected] in a rat model of postprandial lipemia

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

Safety considerations for statins

1 reference

12 December 2020

Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia

1 reference

12 December 2020

Effects of administration of di-(2-ethylhexyl)phthalate on rat liver mitochondria

1 reference

12 December 2020

Tamoxifen-associated steatohepatitis--report of three cases

1 reference

12 December 2020

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

12 December 2020

Tamoxifen-induced steatohepatitis

1 reference

12 December 2020

Aromatase-deficient (ArKO) mice are retrieved from severe hepatic steatosis by peroxisome proliferator administration

1 reference

12 December 2020

Clinical features and natural history of nonalcoholic steatosis syndromes

1 reference

12 December 2020

Medical significance of peroxisome proliferator-activated receptors.

1 reference

12 December 2020

Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis

1 reference

12 December 2020

Cirrhosis with steatohepatitis after adjuvant tamoxifen

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S11745-003-1093-X

Identifiers

DOI

1 reference

3 December 2017

1 reference